Advertisement

PDCO

Patterson Companies, Inc.

Healthcare

Set alert

Price alert · PDCO

All alert types
31.33 0.00 0.00%
As of Apr 17, 2025
31.33 Day range 31.33

52-week range unavailable

Open
31.33
Prev close
31.33
Mkt cap
2.77B
Vol
6.77M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
3.32%
More statistics
Low
31.33
High
31.33
Forward P/E
12.43
Beta
0.72
Short ratio
2.52
Inst. own
94.31%
Dividend
1.04
Ex-div date
Oct 17, 2024
Earnings
Feb 26, 2025
50-d avg
31.14
200-d avg
26.45
1y target
0.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for PDCO has not been loaded yet. Try again in a moment.

Key statistics

Market cap
2.77B
Enterprise value
3.51B
Trailing P/E
20.48
Forward P/E
12.43
PEG ratio
0.00
Price / sales
0.43
Price / book
2.80
EPS (TTM)
1.53
Beta
0.72
Dividend yield
3.32%
Payout ratio
50.98%
Profit margin
2.13%
Revenue (TTM)
6.51B
Revenue growth
-2.70%
Free cash flow
95.47M
Total cash
137.34M
Total debt
879.78M
Return on equity
14.11%
Shares outstanding
88.47M
Short % of float
4.23%
50-day average
31.14
200-day average
26.45

Analyst view

Consensus: hold

Hold
Price target (mean) 0.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Feb 26, 2025

Expected Feb 26, 2025. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
PDCO Revenue — quarterly 1.57B
2021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 2024
PDCO Net income — quarterly 31.25M
2021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 2024
PDCO EPS — quarterly 0.35
2021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20212022-Q4 20222023-Q1 20222023-Q2 20222023-Q3 20222023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 2024

Earnings

PDCO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 26, 2025Jan 1, 20250.62———
Dec 5, 2024Oct 1, 20240.49———
Aug 28, 2024Jul 1, 20240.32———
Jun 18, 2024Apr 1, 20240.83———
Feb 28, 2024Jan 1, 20240.60———
Nov 29, 2023Oct 1, 20230.59———

Upgrades / downgrades

PDCO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024Morgan StanleymainEqual-WeightEqual-Weight
Dec 12, 2024BairdmainNeutralNeutral
Dec 11, 2024Leerink PartnersdownOutperformMarket Perform
Dec 6, 2024Piper SandlermainNeutralNeutral
Dec 6, 2024BairdmainNeutralNeutral
Dec 5, 2024StifelmainHoldHold

About Patterson Companies, Inc.

Patterson Companies, Inc. engages in the distribution of dental and animal health products. The company operates through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; and practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, and patient engagement solutions, as well as clinical and patient education systems. This segment also provides a range of related services comprising software and design, maintenance and repair, and equipment financing services. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, and equipment, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. Patterson Companies, Inc. was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is based in Saint Paul, Minnesota with additional locations in Loveland, Colorado; Edmonton, Alberta; Stoke-on-Trent, United Kingdom.

Sector
Healthcare
Industry
Medical Distribution
Country
United States

News

Your note

Sign in to keep a note on PDCO — it syncs with the Stock Master app.

Insider holders

PDCO insider holders
InsiderRelationLatest transactionDateShares held
BARRY KEVIN M. J.D.Chief Financial OfficerStock Award(Grant)Apr 16, 20250
BERGESON SAMANTHA LOfficerStock Award(Grant)Apr 16, 20250
BLANCO ALEX NDirectorStock Award(Grant)Sep 15, 202441,300
FERAGEN JODY HDirectorStock Award(Grant)Sep 15, 202457,145
FRENZEL ROBERT CDirectorStock Award(Grant)Sep 15, 202438,242
KORSH LESLIE BRIANOfficerStock Award(Grant)Apr 16, 20250

Institution ownership

PDCO institution ownership
Holder% heldSharesValueReported
Blackrock Inc.14.40%12,738,451399.10MDec 30, 2024
Vanguard Group Inc10.64%9,409,915294.81MDec 30, 2024
Dimensional Fund Advisors LP3.99%3,534,010110.72MDec 30, 2024
State Street Corporation3.76%3,326,024104.20MDec 30, 2024
American Century Companies Inc3.06%2,711,03084.94MDec 30, 2024
Morgan Stanley2.45%2,165,97567.86MDec 30, 2024

Fund ownership

PDCO fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.51%4,875,811152.76MMar 30, 2025
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.83%2,499,48578.31MDec 30, 2024
iShares Trust-iShares Russell 2000 ETF2.34%2,071,02264.89MMar 30, 2025
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.28%2,020,59563.31MDec 30, 2024
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund1.52%1,340,86442.01MDec 30, 2024
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.35%1,193,00437.38MDec 30, 2024
Advertisement